These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33181159)

  • 21. Emergency department triage prediction of clinical outcomes using machine learning models.
    Raita Y; Goto T; Faridi MK; Brown DFM; Camargo CA; Hasegawa K
    Crit Care; 2019 Feb; 23(1):64. PubMed ID: 30795786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Multiplexed Plasma Biomarker Panel Has Diagnostic and Prognostic Potential in Children With Hypertrophic Cardiomyopathy.
    Captur G; Doykov I; Chung SC; Field E; Barnes A; Zhang E; Heenan I; Norrish G; Moon JC; Elliott PM; Heywood WE; Mills K; Kaski JP
    Circ Genom Precis Med; 2024 Jun; 17(3):e004448. PubMed ID: 38847081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance.
    Augusto JB; Davies RH; Bhuva AN; Knott KD; Seraphim A; Alfarih M; Lau C; Hughes RK; Lopes LR; Shiwani H; Treibel TA; Gerber BL; Hamilton-Craig C; Ntusi NAB; Pontone G; Desai MY; Greenwood JP; Swoboda PP; Captur G; Cavalcante J; Bucciarelli-Ducci C; Petersen SE; Schelbert E; Manisty C; Moon JC
    Lancet Digit Health; 2021 Jan; 3(1):e20-e28. PubMed ID: 33735065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A machine learning approach to predict early outcomes after pituitary adenoma surgery.
    Hollon TC; Parikh A; Pandian B; Tarpeh J; Orringer DA; Barkan AL; McKean EL; Sullivan SE
    Neurosurg Focus; 2018 Nov; 45(5):E8. PubMed ID: 30453460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).
    Bhattacharya M; Lu DY; Kudchadkar SM; Greenland GV; Lingamaneni P; Corona-Villalobos CP; Guan Y; Marine JE; Olgin JE; Zimmerman S; Abraham TP; Shatkay H; Abraham MR
    Am J Cardiol; 2019 May; 123(10):1681-1689. PubMed ID: 30952382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Feasibility of the 2014 European guidelines risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy in Chinese patients].
    Zhu SH; Li Y; Huang W; Jiang H; Li SN; Chen L; Huang S; Yu HS; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 May; 45(5):404-408. PubMed ID: 28511325
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
    Chaowu Y; Shihua Z; Jian L; Li L; Wei F
    Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
    Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
    BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
    Wu G; Liu J; Wang S; Yu S; Zhang C; Wang D; Zhang M; Yang Y; Kang L; Zhao S; Hui R; Zou Y; Wang J; Song L
    Heart; 2021 Oct; 107(19):1576-1583. PubMed ID: 33361398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of ventricular tachyarrhythmia in patients with hypertrophic cardiomyopathy with machine learning-based texture analysis of late gadolinium enhancement cardiac MRI.
    Alis D; Guler A; Yergin M; Asmakutlu O
    Diagn Interv Imaging; 2020 Mar; 101(3):137-146. PubMed ID: 31727603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.
    Magrì D; Limongelli G; Re F; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Musumeci B; Maruotti A; Volpe M; Autore C
    Heart; 2016 Apr; 102(8):602-9. PubMed ID: 26849900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
    Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical characteristics and outcome of patients with dilated-hypertrophic cardiomyopathy].
    Li PR; Li XL; Xu F; Gou C; Deng MJ; Liu JQ; Wang K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):327-30. PubMed ID: 27112611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
    Maron BJ; Rowin EJ; Casey SA; Haas TS; Chan RH; Udelson JE; Garberich RF; Lesser JR; Appelbaum E; Manning WJ; Maron MS
    Circulation; 2013 Feb; 127(5):585-93. PubMed ID: 23275385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.
    Fauchier L; Bisson A; Bodin A; Herbert J; Spiesser P; Pierre B; Clementy N; Bernard A; Babuty D; Lip GYH
    Stroke; 2022 Feb; 53(2):497-504. PubMed ID: 34601900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score.
    Östman-Smith I; Sjöberg G; Alenius Dahlqvist J; Larsson P; Fernlund E
    Acta Paediatr; 2021 Nov; 110(11):3105-3115. PubMed ID: 34314540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Dhillon A; Khanna A; Randhawa MS; Cywinski J; Saager L; Thamilarasan M; Lever HM; Desai MY
    Heart; 2016 Oct; 102(20):1627-32. PubMed ID: 27288277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death.
    Sugiura Y; Morimoto R; Aoki S; Yamaguchi S; Haga T; Kuwayama T; Yokoi T; Hiraiwa H; Kondo T; Watanabe N; Kano N; Fukaya K; Sawamura A; Okumura T; Murohara T
    Heart Vessels; 2019 Dec; 34(12):2002-2010. PubMed ID: 31152200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.